Gastrointestinal risk profile of tigecycline, omadacycline and eravacycline: Evidence from the FDA adverse event reporting system
By: Zhu Wang, Guoping Gan and Haiping Yao
Language: English
Page range: 1 - 20
Accepted on: Nov 24, 2025
Published on: Mar 25, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Zhu Wang, Guoping Gan, Haiping Yao, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.